The trademark application FIVERIXIN was filed by Promedo Pharma Products GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 24, 2022, and it was registered by office on July 1, 2022 without any oppositions.
The application was filed in Polish (English was selected as the second language).